INDUSTRY & BUSINESS
Theae Successes A g a i n s t D i s e a s e 1 9 4 5 - 5 6 decline in death rates p e r 1 0 0 , 0 0 0 population for diseases against which antibiotics a r e effective
* «—
wr
uina
«ι=
w Ο es
Β
Down
33%
*Λ
o
v>>
Β Ο
il!
a
-a ο
J» SE
Down
Down 71%
Down 71%
Dawn 78f 0
Down 85%
Down 89%
Source: U S- Public Health Service
Down 92%
, . » P r e m i s e a H e f t y Sales G r o w t h for Antibiotics Forecast of Domestic Human Dosage—Form Antibiotic Sales at Manufacturers Level /Aillions of Dollars
$444
1958.. .
1960
1962
1964
1965
Source: G. B. Stone, "A Long Range Economic Outlook for the Ethical Drug Industry."
Antibiotics Keep Climbing Sales hit $380 million in 1958 for human uses alone, will lump another 1 5 % by 1965 ^ALXTIBIOTICS SALES hit a new high in
1958. Total value of antibiotics sold by the pharmaceutical industry for h u m a n medicines is estimated at $380 million, according to John E. McKeen, president of C h a s . Pfizer. Another $70 million worth went into feed supple ments, veterinary drugs, pesticides, pre servatives, and other miscellaneous products, M c K e e n told the Midwest Forum of t h e Investment Analysts So ciety of Chicago. McKeen also says mat anuuiolics sales will continue to rise, thanks to a
growing population and research dis coveries. By 1965, he says, sales at the manufacturers' level should climb another 15'/* for human use alone—up to $440 million. And more antibiotics will be used in agriculture and industry. Research, says McKeen, is the key to the drug industry's growth. In 1959. pharmaceutical firms will spend something like $190 million for re search, or 7 cents out of every sales dol lar (compared to the general industry average tu 1 eeni ;. -Moreover, piiarrnaceutical development abroad will spur
the drug industry to greater achieve ments. He cites the forthcoming (in 1961) International Public Health a n d Medical Research Year. The Medical Year, McKeen notes, will focus world wide attention on disease, medical tech niques, and research. Post-war antibiotics research and use has caused a major drop in the death rate for eight infectious diseases, says McKeen. Average drop is 58V
